Levels of GFAP, NfL and T-tau levels were restored after ~2 months of recovery in moderate and severe COVID-19 patients (Figure 1), and there were no significant differences between patients with and without neurological symptoms as part of post-acute infection sequelae. Here, GFAP is linked to COVID-19.